The Trade Mission in France introduces companies to a highly specialized ecosystem in clinical genomics, personalized therapy, and advanced molecular analysis. The agenda facilitates strategic links with leading hospitals, research institutes, and biotechnology actors focused on prediction models and applied pharmacogenomics. France prioritizes integrated digital health projects, allowing exploration of pilots with omic data and precision diagnostic solutions. This environment boosts scientific collaboration and commercial expansion of innovative technologies.
